TU-100

DB12467InvestigationalSmall molecule

TU-100 has been used in trials studying the treatment of Abdominal Pain, Colonic Transit, Crohn's Disease, Rectal Sensation, and Gastric Emptying, among others.

Mechanism: Pharmacologically active on Transient receptor potential cation channel subfamily A member 1
Curator reviewed
Formula / weight: C₂₀H₁₃NO₃ · 315.328 g/mol (avg)
Code names: TU-100

Resolves to

Compound

UNIIN3KQ8A1E0XCAS1310907-71-1PubChem72942015

Structure

InChIKeyKAYRGFYBCCETPE-UHFFFAOYSA-NSMILESCN1C2C3=C(C1C1=CC=CC=C1C2=O)C(=O)C1=CC=CC=C1C3=O

Targets

O75762TRPA1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with TU-100, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account